Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer
Ontology highlight
ABSTRACT: To evaluate the safety of karillizumab combined with apatinib mesylate, XELOX and radiofrequency ablation
DISEASE(S): Hepatic Metastasis Of Colorectal Cancer,Neoplasm Metastasis,Colorectal Neoplasms
PROVIDER: 2324991 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA